| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $766.2M | — | +2.8% |
| Cost of Revenue | $195.0M | — | +28.7% |
| R&D Expense | $178.8M | — | +12.6% |
| SG&A Expense | $258.3M | — | +25.3% |
| Operating Income | $129.6M | — | -42.1% |
| Interest Expense | $9.6M | — | +301.0% |
| Pre-tax Income | $141.2M | — | -40.7% |
| Income Tax | $35.7M | — | -31.9% |
| Net Income | $105.5M | — | -43.2% |
| EPS (Basic) | $0.55 | — | -43.3% |
| EPS (Diluted) | $0.54 | — | -43.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.22B | +69.4% | +111.9% |
| Accounts Receivable | $903.9M | -0.5% | +22.3% |
| Inventory | $1.27B | -2.0% | -0.1% |
| Current Assets | $4.61B | +16.5% | +32.8% |
| Total Assets | $8.59B | +13.1% | +20.2% |
| Current Liabilities | $793.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $220.7M | — | +26.5% |
| Capital Expenditures | $20.9M | — | +24.8% |
| Investing Cash Flow | $725.5M | — | +2669.3% |
| Financing Cash Flow | $813.2M | — | +2196.9% |
| Free Cash Flow | $199.7M | — | +26.7% |
| +26.3% |
| Long-term Debt | $1.43B | +139.5% | — |
| Total Liabilities | $2.38B | +57.9% | +75.8% |
| Stockholders' Equity | $6.21B | +2.1% | +7.2% |